#65 Tony Keating - Co-Founder of ResApp

The Dion Guagliardo Podcast

ResApp is a biotech company that commercialised technology to diagnose respiratory illnesses based on an audio recording of a patient’s cough on their phone. After proving immensely useful for diagnosing COVID-19 during the height of pandemic, Pfizer acquired the company for $180 million.

Throughout the episode, Tony discusses the path of listing on the ASX early-on and how that provided the initial capital needed for the company to succeed. Coming from a research background, Tony also talks about how his experience as a scholar and background in engineering contributes to being an effective CEO.

If you enjoy this episode, feel free to share with family and friends and leave a 5 star review.

Share the episode: https://thedionguagliardopodcast.buzzsprout.com/share
More on us!

Dion's Newsletter: http://eepurl.com/hHg1ff

Our social media: https://linktr.ee/FortressFinancial

Fortress Family Office: https://www.fortressfamilyoffice.com/

Contact us: [e-mail]

Kapitel

1. Highlight Clip (00:00:00)

2. Introduction (00:00:41)

3. Guest Background and Introduction (00:02:09)

4. Why did Tony Keating List ResApp on the ASX (00:02:52)

5. What is ResApp and The Journey So Far (00:04:51)

6. Was Tony Keating Always Entrepreneurial? (00:07:11)

7. What Advantages does Tony's Engineering Give Him as CEO (00:10:47)

8. Who did Tony Keating Turn To in Times of Need? (00:18:22)

9. Tony Keating's Biggest Strength and How it Helped Him Succeed with ResApp (00:19:13)

10. What was the Biggest Learning Tony Keating had when Leading ResApp (00:19:39)

11. Most Difficult Point for Tony Keating in the ResApp Journey (00:22:35)

12. How Tony Keating Manged ResApp Staff Morale During Tough Times (00:26:12)

13. The Best Advice Tony Keating was Given for ResApp (00:30:15)

14. Tony Keating's Biggest Inspirations (00:31:48)

15. The Business Books that Taught Tony Keating Success (00:33:20)

16. Outtro (00:35:54)